Cornerstone Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556K Buy
4,623
+66
+1% +$7.62K 0.06% 80
2025
Q4
$480K Buy
4,557
+459
+11% +$43.1K 0.05% 80
2025
Q3
$344K Sell
4,098
-1,400
-25% -$115K 0.03% 88
2025
Q2
$435K Hold
5,498
0.05% 77
2025
Q1
$494K Hold
5,498
0.05% 76
2024
Q4
$547K Sell
5,498
-70
-1% -$7.22K 0.06% 77
2024
Q3
$632K Sell
5,568
-175
-3% -$20.8K 0.06% 78
2024
Q2
$711K Buy
5,743
+1,170
+26% +$151K 0.07% 65
2024
Q1
$603K Sell
4,573
-670
-13% -$82.6K 0.06% 70
2023
Q4
$572K Hold
5,243
0.06% 73
2023
Q3
$540K Sell
5,243
-270
-5% -$29.1K 0.07% 68
2023
Q2
$636K Hold
5,513
0.07% 68
2023
Q1
$587K Sell
5,513
-604
-10% -$65.2K 0.07% 67
2022
Q4
$679K Sell
6,117
-1,061
-15% -$108K 0.09% 65
2022
Q3
$618K Buy
7,178
+339
+5% +$30.3K 0.09% 62
2022
Q2
$624K Hold
6,839
0.08% 63
2022
Q1
$561K Sell
6,839
-165
-2% -$13K 0.06% 66
2021
Q4
$537K Sell
7,004
-899
-11% -$71.6K 0.06% 68
2021
Q3
$594K Sell
7,903
-151
-2% -$11.5K 0.07% 66
2021
Q2
$626K Sell
8,054
-228
-3% -$17K 0.07% 65
2021
Q1
$609K Sell
8,282
-1,104
-12% -$81.4K 0.07% 64
2020
Q4
$733K Buy
9,386
+1,425
+18% +$109K 0.09% 56
2020
Q3
$630K Buy
7,961
+1,572
+25% +$123K 0.09% 53
2020
Q2
$471K Buy
6,389
+331
+5% +$24.9K 0.08% 55
2020
Q1
$445K Sell
6,058
-278
-4% -$21.8K 0.09% 50
2019
Q4
$550K Sell
6,336
-624
-9% -$51.3K 0.08% 64
2019
Q3
$559K Sell
6,960
-209
-3% -$16.8K 0.09% 58
2019
Q2
$574K Hold
7,169
0.09% 59
2019
Q1
$569K Sell
7,169
-944
-12% -$70.6K 0.09% 57
2018
Q4
$591K Sell
8,113
-183
-2% -$12.9K 0.11% 60
2018
Q3
$562K Hold
8,296
0.09% 62
2018
Q2
$481K Buy
8,296
+26
+0.3% +$1.47K 0.08% 61
2018
Q1
$430K Sell
8,270
-57
-0.7% -$3.08K 0.07% 65
2017
Q4
$447K Hold
8,327
0.08% 65
2017
Q3
$509K Sell
8,327
-1,794
-18% -$109K 0.09% 60
2017
Q2
$619K Sell
10,121
-628
-6% -$38.2K 0.12% 52
2017
Q1
$652K Buy
10,749
+57
+0.5% +$3.46K 0.13% 53
2016
Q4
$601K Hold
10,692
0.13% 55
2016
Q3
$637K Hold
10,692
0.14% 52
2016
Q2
$588K Buy
10,692
+839
+9% +$44.7K 0.13% 50
2016
Q1
$497K Hold
9,853
0.11% 51
2015
Q4
$497K Sell
9,853
-4,355
-31% -$220K 0.11% 50
2015
Q3
$670K Sell
14,208
-2,138
-13% -$114K 0.17% 51
2015
Q2
$888K Buy
16,346
+11,623
+246% +$652K 0.2% 49
2015
Q1
$259K Sell
4,723
-131
-3% -$7.42K 0.07% 58
2014
Q4
$263K Hold
4,854
0.07% 60
2014
Q3
$275K Hold
4,854
0.08% 61
2014
Q2
$268K Hold
4,854
0.07% 60
2014
Q1
$263K Sell
4,854
-1,048
-18% -$54.3K 0.08% 59
2013
Q4
$282K Hold
5,902
0.08% 57
2013
Q3
$268K Sell
5,902
-785
-12% -$35.8K 0.08% 57
2013
Q2
$296K Buy
+6,687
New +$299K 0.1% 52

Other funds holding MRK

Cornerstone Capital's MRK Position: Q1 2026 in Review

Cornerstone Capital increased its Merck (MRK) stake by 1.4% in Q1 2026, buying an estimated $7.62K and bringing the position to 4,623 shares worth $556K. The position accounts for 0.06% of the portfolio, ranked #80.

Cornerstone Capital first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $888K in Q2 2015. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cornerstone Capital held 4,623 shares of Merck worth $556K as of Q1 2026.
  • Cornerstone Capital bought 66 Merck shares in Q1 2026, an estimated $7.62K.
  • Merck made up 0.06% of Cornerstone Capital's portfolio in Q1 2026, its #80 holding.
  • Cornerstone Capital first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Cornerstone Capital's Merck position peaked at $888K in Q2 2015.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cornerstone Capital's 13F filing for Q1 2026, filed 12 May 2026.